The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Is Witnessing Impact From Rising Eye Disorders Driving Demand For The Market Due To Increasing Digital Eye Strain And Vision Impairments
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Expected To Scale Between 2026 And 2030?
The ophthalmic artificial intelligence-assisted diagnosis market has seen rapid expansion in recent years. It is anticipated to increase from $2.17 billion in 2025 to $2.57 billion in 2026, achieving a compound annual growth rate (CAGR) of 18.5%. The historical growth of this market can be attributed to factors like the growing adoption of digital imaging devices, a rise in the prevalence of eye diseases, increased awareness regarding early diagnosis, the integration of AI in clinical trials, and advancements in retinal imaging technology.
The ophthalmic artificial intelligence-assisted diagnosis market is projected to expand significantly in the coming years. It is anticipated to reach a valuation of $5.03 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 18.2%. This projected growth throughout the forecast period stems from several factors, including the proliferation of cloud-based AI diagnostic platforms, the broadening of tele-ophthalmology services, advancements in AI algorithms for diagnosing rare eye conditions, increased collaborations between AI developers and healthcare facilities, and the rising uptake of predictive ophthalmology. Key trends expected during this period involve AI-driven retinal imaging analysis, disease detection enhanced by deep learning, the development of predictive ophthalmology models, automated analysis of patient records, and the seamless incorporation of AI into existing clinical procedures.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Primary Drivers Are Impacting The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Growth?
The increasing occurrence of eye conditions is anticipated to drive expansion in the ophthalmic artificial intelligence-assisted diagnosis market moving forward. Eye disorders are medical issues or anomalies impacting the eye’s structure or function, potentially harming vision or ocular health. The rise in eye disorders stems from greater digital device screen time, leading to digital eye strain, dryness, and prolonged vision problems due to extended blue light exposure and decreased blinking. Ophthalmic artificial intelligence-assisted diagnosis provides assistance through the analysis of medical imaging and patient information to identify, categorize, and foresee eye disorders precisely and at an early stage, facilitating prompt treatment and mitigating the potential for vision loss. For example, data from August 2023, as reported by the World Health Organization (WHO), a United Nations agency located in Switzerland, indicates that over 2.2 billion individuals globally experience near or distance vision impairment in 2023, with more than 1 billion of these cases being preventable or currently untreated. Refractive errors and cataracts continue to be the primary contributors, yet only 36% of those with refractive error-related impairment and a mere 17% of those with cataract-related impairment have access to effective treatments. Consequently, the growing occurrence of eye conditions is fueling the expansion of the ophthalmic artificial intelligence-assisted diagnosis market.
How Are Segments Identified Within The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Segment Framework?
The ophthalmic artificial intelligence-assisted diagnosis market covered in this report is segmented –
1) By Type: Cloud-Based, On-Premises
2) By Technology: Deep Learning, Machine Learning, Computer Vision, Other Technologies
3) By Application: Hospital, Clinic, Imaging Centre
Subsegments:
1) By Cloud-Based: Public Cloud, Private Cloud, Hybrid Cloud
2) By On-Premises: Local Server Deployment, Enterprise Data Center Deployment, Private Network Deployment
Which Trends Are Shaping Growth In The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market?
Leading companies in the ophthalmic artificial intelligence-assisted diagnosis market are concentrating on developing innovative solutions, such as an ocular data-as-a-service platform, to improve diagnostic precision, optimize patient management, and offer predictive understanding for eye conditions. An ocular data-as-a-service platform is a digital solution that provides eye health information on demand, enabling ophthalmologists, medical centers, and AI diagnostic instruments to remotely obtain, exchange, and examine retinal scans and other eye-related data for better diagnosis, surveillance, and research. For example, in May 2025, Topcon Healthcare Solutions Inc., a US-based digital healthcare solutions company, introduced IDHea, which aims to simplify ophthalmic diagnostics and enhance patient outcomes. This cloud-based platform accelerates AI and digital health advancements by offering rapid, protected access to real-world and clinical ocular datasets. It empowers researchers to achieve significant progress in the care of both eye and systemic diseases by converting clinical data into practical, AI-driven insights. Developed adhering to the FAST principle—Fast, Accessible, Safe, and Transparent—IDHea facilitates predictive, personalized, and proactive patient care, all while maintaining strict privacy and governance protocols.
Who Are The Companies Competing Within The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market?
Major companies operating in the ophthalmic artificial intelligence-assisted diagnosis market are IDx Technologies Inc., Digital Diagnostics Inc., AEYE Health Inc., Eyenuk Inc., OphtAI, Oivi Tech Private Limited, Altris Inc., JuneBrain Inc., Mediwhale Inc., MONA.health BV, Remidio Innovative Solutions Pvt. Ltd., Retinalyze System A/S, Retmarker, RetinaRisk, Ikerian AG, VoxelCloud Inc., Visulytix Ltd., Aiforia Technologies Plc, DeepTek Inc., EyRIS Pte Ltd., Neurodynamics Solutions Inc.
Get The Full Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Report:
Which Region Accounts For The Largest Portion Of The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market?
North America was the largest region in the ophthalmic artificial intelligence-assisted diagnosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ophthalmic artificial intelligence-assisted diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market 2026, By The Business Research Company
Ophthalmic Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/ophthalmic-devices-global-market-report
Ophthalmic Workstations Market Report 2026
https://www.thebusinessresearchcompany.com/report/ophthalmic-workstations-global-market-report
Artificial Intelligence In The Diagnostic Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
